---
import BaseLayout from '../layouts/BaseLayout.astro';
import { BackgroundShapes } from '../components';
---

<BaseLayout title="Sarkome — Roadmap" description="Mission: To algorithmically identify, validate, and license therapeutic assets for Alveolar Soft Part Sarcoma (ASPSCR1-TFE3) without building physical infrastructure.">
  <BackgroundShapes />
  <div class="min-h-screen-section">
    <div class="container-main z-10">
      <h1 class="page-title">Roadmap</h1>

      <div class="space-y-8 text-gray-800">
        <div class="card-sm">
          <h2 class="text-2xl font-bold text-purple-700 mb-3">Mission</h2>
          <p class="mb-2">To algorithmically identify, validate, and license therapeutic assets for Alveolar Soft Part Sarcoma (ASPSCR1-TFE3) without building physical infrastructure.</p>

          <h2 class="text-2xl font-bold text-purple-700 mt-6 mb-3">Architecture</h2>
          <p class="mb-2">Agentic AI (In Silico) → CRO Validation (Wet Lab) → IP Licensing (Commercial)</p>
        </div>

        <div class="card-sm">
          <h2 class="text-2xl font-bold text-purple-700 mb-3">1. System Architecture</h2>
          <p class="mb-3">This project does not build a "platform" first. It builds a Product Pipeline. We operate as a "Single Asset Entity" (SAE)—a company that exists solely to find and sell one specific drug asset.</p>

          <h3 class="font-semibold mt-4">The Pipeline Flow</h3>
          <ul class="list-disc list-inside ml-4">
            <li>Input: Global biomedical data (PubMed, ChEMBL, PDB)</li>
            <li>Processing: A stack of 3 AI Agents filters noise to find signal</li>
            <li>Output: A Target Product Profile (TPP) ready for wet-lab purchase</li>
          </ul>
        </div>

        <div class="card-sm">
          <h2 class="text-2xl font-bold text-purple-700 mb-3">2. Technical Stack (The "Agentic Core")</h2>
          <p class="mb-3">We replace a human R&D team with three specific software agents.</p>

          <h3 class="font-semibold">Agent A: The Miner (Knowledge Extraction)</h3>
          <p class="italic">Function:</p>
          <p>Scrapes unstructured text to find hidden relationships.</p>
          <p class="mt-2"><strong>Tech Stack:</strong> Python, LangChain, PubMed API, LLM</p>
          <p class="mt-2"><strong>Logic:</strong></p>
          <ul class="list-disc list-inside ml-4">
            <li>Query PubMed for <em>TFE3</em> AND (Kinase OR Inhibitor)</li>
            <li>Use LLM to extract entity pairs: (Drug X) --inhibits--> (Target Y)</li>
            <li>Filter for targets that interact with the TFE3 fusion protein</li>
            <li>Output: <strong>candidates_raw.json</strong> (List of ~50 potential drugs)</li>
          </ul>

          <h3 class="font-semibold mt-4">Agent B: The Physicist (Structural Validation)</h3>
          <p class="italic">Function:</p>
          <p>Simulates physics to see if the drug fits the target.</p>
          <p class="mt-2"><strong>Tech Stack:</strong> Google Colab, AlphaFold 3, DiffDock</p>
          <p class="mt-2"><strong>Logic:</strong></p>
          <ul class="list-disc list-inside ml-4">
            <li>Generate 3D PDB structure of ASPSCR1-TFE3 IDR</li>
            <li>Dock each candidate from Agent A into the protein pocket</li>
            <li>Calculate Gibbs Free Energy (ΔG). Threshold: If Binding Energy &gt; -8.0 kcal/mol, DISCARD</li>
            <li>Output: <strong>docked_results.csv</strong> (Ranked list of ~10 high-fit drugs)</li>
          </ul>

          <h3 class="font-semibold mt-4">Agent C: The Skeptic (Safety & Tox)</h3>
          <p class="italic">Function:</p>
          <p>Checks for chemical toxicity and commercial viability.</p>
          <p class="mt-2"><strong>Tech Stack:</strong> RDKit, ChEMBL API, Tox21 Database</p>
          <p class="mt-2"><strong>Logic:</strong></p>
          <ul class="list-disc list-inside ml-4">
            <li>Check molecular weight (&lt;500 Da for oral bioavailability)</li>
            <li>Flag PAINS (Pan-Assay Interference Compounds)</li>
            <li>Check prior FDA toxicity flags</li>
            <li>Output: <strong>final_shortlist.md</strong> (Top 3 Candidates)</li>
          </ul>
        </div>

        <div class="card-sm">
          <h2 class="text-2xl font-bold text-purple-700 mb-3">3. Execution Roadmap (2026–2031)</h2>

          <h3 class="font-semibold mt-2">Phase 1: Signal Identification (2026 Q1)</h3>
          <ul class="list-disc list-inside ml-4">
            <li>Initialize this repository structure</li>
            <li>Run <strong>miner_agent.py</strong> to scan 50,000 abstracts</li>
            <li>Run <strong>docking_agent.py</strong> on the top hits</li>
            <li>Generate the Target Product Profile (TPP) document</li>
          </ul>

          <h3 class="font-semibold mt-3">Phase 2: Biological Proof (2026 Q2–Q4)</h3>
          <ul class="list-disc list-inside ml-4">
            <li>Synthesize: Order small batches (5–10 mg) of the Top 3 compounds from a synthesis CRO (e.g., WuXi AppTec)</li>
            <li>Validate: Ship compounds to a biology CRO (e.g., Charles River)</li>
            <li>Assays: Cell Viability (IC50 on ASPS-1), Western Blot (TFE3 levels)</li>
            <li>Success Metric: IC50 &lt; 100 nM</li>
          </ul>

          <h3 class="font-semibold mt-3">Phase 3: Regulatory Asset Generation (2027)</h3>
          <ul class="list-disc list-inside ml-4">
            <li>ADME/Tox panels</li>
            <li>Submit Pre-IND meeting request to FDA</li>
            <li>Propose a Basket Trial combining ASPS and RCC with TFE3 fusions</li>
          </ul>

          <h3 class="font-semibold mt-3">Phase 4: The Exit (2028)</h3>
          <ul class="list-disc list-inside ml-4">
            <li>Package AI predictions + Wet Lab proof + FDA minutes</li>
            <li>Pitch to Pharma for licensing (Upfront + Royalties)</li>
          </ul>

          <h3 class="font-semibold mt-3">Phase 5: Scale & Automation (2029–2031)</h3>
          <ul class="list-disc list-inside ml-4">
            <li>2029: Re-invest to target Epithelioid Sarcoma</li>
            <li>2030: Launch ASPS Atlas API</li>
            <li>2031: Automate discovery with Cloud Labs for fully robotic pipelines</li>
          </ul>
        </div>

      </div>
    </div>
  </div>
</BaseLayout>


